Century Sage Scientific Holdings Limited
HKEX:1450.HK
1.34 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q2 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 641.655 | 432.68 | 288.453 | 137.153 | 91.74 | 111.048 | 100.349 | 52.957 | 72.259 | 118.771 | 191.926 | 289.443 | 371.898 | 290.99 | 364.183 | 259.249 | 495.738 | 252.797 | 449.064 | 179.694 | 157.19 |
| Cost of Revenue
| 326.078 | 188.319 | 153.53 | 82.28 | 60.261 | 82.196 | 62.319 | 35.136 | 58.592 | 83.851 | 148.047 | 211.495 | 261.142 | 206.474 | 260.7 | 179.788 | 340.012 | 177.571 | 306.854 | 128.344 | 108.8 |
| Gross Profit
| 315.577 | 244.361 | 134.923 | 54.873 | 31.479 | 28.852 | 38.03 | 17.821 | 13.667 | 34.92 | 43.879 | 77.948 | 110.756 | 84.516 | 103.483 | 79.461 | 155.726 | 75.226 | 142.21 | 51.35 | 48.39 |
| Gross Profit Ratio
| 0.492 | 0.565 | 0.468 | 0.4 | 0.343 | 0.26 | 0.379 | 0.337 | 0.189 | 0.294 | 0.229 | 0.269 | 0.298 | 0.29 | 0.284 | 0.307 | 0.314 | 0.298 | 0.317 | 0.286 | 0.308 |
| Reseach & Development Expenses
| 0 | 0 | 0.027 | 0 | 0.175 | 0 | 1.958 | 7.86 | 5.544 | 9.998 | 9.4 | 0 | 1.751 | 0 | 0.339 | 0 | 0.02 | 0 | 5.275 | 0 | 0 |
| General & Administrative Expenses
| 85.263 | 88.383 | 58.724 | 49.123 | 33.621 | 42.551 | 56.401 | 23.158 | 86.117 | 22.879 | 26.925 | 45.838 | 52.737 | 40.366 | 40.071 | 45.776 | 36.493 | 41.558 | 38.522 | 24.406 | 15.732 |
| Selling & Marketing Expenses
| 153.943 | 107.735 | 44.561 | 26.299 | 6.948 | 3.981 | 5.794 | 5.128 | 10.66 | 9.265 | 13.107 | 14.563 | 21.979 | 13.498 | 23.09 | 11.595 | 21.525 | 11.042 | 18.44 | 14.916 | 8.339 |
| SG&A
| 246.039 | 196.118 | 103.377 | 75.422 | 46.693 | 46.532 | 83.962 | 28.286 | 98.833 | 32.144 | 40.032 | 60.401 | 74.716 | 53.864 | 63.161 | 57.371 | 58.018 | 52.6 | 56.962 | 39.322 | 24.071 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 216.057 | 191.248 | 104.007 | 77.661 | 74.53 | 43.528 | 103.009 | 41.02 | 81.236 | 42.317 | 41.382 | 57.45 | 73.969 | 51.527 | 63.767 | 56.577 | 63.107 | 52.393 | 56.248 | 39.675 | 24.071 |
| Operating Income
| 78.637 | 48.243 | 34.312 | -20.549 | -9.774 | -17.68 | -36.75 | -15.337 | -73.564 | -4.738 | 0.749 | 19.671 | 38.513 | 31.773 | 43.642 | 22.884 | 98.103 | 22.833 | 85.833 | 11.675 | 24.319 |
| Operating Income Ratio
| 0.123 | 0.111 | 0.119 | -0.15 | -0.107 | -0.159 | -0.366 | -0.29 | -1.018 | -0.04 | 0.004 | 0.068 | 0.104 | 0.109 | 0.12 | 0.088 | 0.198 | 0.09 | 0.191 | 0.065 | 0.155 |
| Total Other Income Expenses Net
| 12.68 | -0.041 | -10.458 | -9.361 | -38.724 | -6.056 | -33.307 | -14.264 | -4.386 | -8.851 | -2.862 | -1.228 | -3.75 | -5.108 | -6.563 | -2.786 | -3.403 | -5.393 | -1.922 | -1.44 | -0.783 |
| Income Before Tax
| 91.317 | 48.202 | 23.854 | -29.91 | -48.498 | -23.736 | -70.057 | -29.601 | -77.95 | -13.589 | -2.113 | 18.443 | 34.763 | 26.665 | 37.079 | 20.098 | 94.7 | 17.44 | 83.911 | 10.235 | 23.537 |
| Income Before Tax Ratio
| 0.142 | 0.111 | 0.083 | -0.218 | -0.529 | -0.214 | -0.698 | -0.559 | -1.079 | -0.114 | -0.011 | 0.064 | 0.093 | 0.092 | 0.102 | 0.078 | 0.191 | 0.069 | 0.187 | 0.057 | 0.15 |
| Income Tax Expense
| 20.599 | 4.949 | 10.25 | 0.085 | 3.603 | 0.093 | 1.584 | 0.117 | 3.783 | 0.888 | 0.103 | 2.947 | 3.7 | 5.181 | 3.66 | 3.43 | 10.366 | 4.721 | 14.583 | 1.808 | 4.098 |
| Net Income
| 75.282 | 44.18 | 17.796 | -27.003 | -40.699 | -20.916 | -68.741 | -28.79 | -71.891 | -12.434 | -2.216 | 14.655 | 29.912 | 21.484 | 33.419 | 16.668 | 84.334 | 12.719 | 69.328 | 8.427 | 19.439 |
| Net Income Ratio
| 0.117 | 0.102 | 0.062 | -0.197 | -0.444 | -0.188 | -0.685 | -0.544 | -0.995 | -0.105 | -0.012 | 0.051 | 0.08 | 0.074 | 0.092 | 0.064 | 0.17 | 0.05 | 0.154 | 0.047 | 0.124 |
| EPS
| 0.055 | 0.032 | 0.015 | -0.025 | -0.038 | -0.02 | -0.066 | -0.028 | -0.07 | -0.012 | -0.002 | 0.014 | 0.029 | 0.022 | 0.033 | 0.017 | 0.083 | 0.017 | 0.092 | 0.011 | 0.026 |
| EPS Diluted
| 0.055 | 0.032 | 0.015 | -0.025 | -0.038 | -0.02 | -0.066 | -0.028 | -0.07 | -0.012 | -0.002 | 0.014 | 0.029 | 0.022 | 0.033 | 0.017 | 0.085 | 0.017 | 0.092 | 0.011 | 0.026 |
| EBITDA
| 85.814 | 52.001 | 35.616 | -17.629 | -7.883 | -14.632 | -35.442 | -9.515 | -71.718 | 1.079 | 6.051 | 27.641 | 44.129 | 38.172 | 49.335 | 28.204 | 103.885 | 26.639 | 90.586 | 15.257 | 24.43 |
| EBITDA Ratio
| 0.134 | 0.12 | 0.123 | -0.129 | -0.086 | -0.132 | -0.353 | -0.18 | -0.993 | 0.009 | 0.032 | 0.095 | 0.119 | 0.131 | 0.135 | 0.109 | 0.21 | 0.105 | 0.202 | 0.085 | 0.155 |